STOCK TITAN

Alyeska discloses 7.17% Cantor Equity Partners II (CEPT) stake

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Alyeska Investment Group and affiliates have disclosed a passive stake in Cantor Equity Partners II, Inc. They report beneficial ownership of 1,763,546 Class A ordinary shares, representing 7.17% of the company’s outstanding common stock, based on 24,580,000 shares reported as outstanding.

The filing is a Schedule 13G, indicating the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Cantor Equity Partners II.

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake in Cantor Equity Partners II (CEPT) did Alyeska report?

Alyeska and related reporting persons disclosed beneficial ownership of 1,763,546 Class A ordinary shares of Cantor Equity Partners II, Inc. This represents 7.17% of the company’s outstanding common stock, based on 24,580,000 shares reported as outstanding in a prior Form 10-Q.

Which entities are reporting beneficial ownership in CEPT on this Schedule 13G?

The Schedule 13G lists three reporting persons: Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh. Each reports the same beneficial ownership figures and shared voting and dispositive power over 1,763,546 Class A ordinary shares of Cantor Equity Partners II, Inc.

How much of CEPT’s share class does Alyeska’s 1,763,546 shares represent?

The reported 1,763,546 Class A ordinary shares represent 7.17% of Cantor Equity Partners II, Inc.’s outstanding common stock. This percentage is calculated using 24,580,000 shares outstanding, as disclosed in the issuer’s Form 10-Q filed on November 14, 2025.

Does the Alyeska Schedule 13G for CEPT indicate an attempt to influence control?

No. The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Cantor Equity Partners II, Inc., consistent with a passive investment reported on Schedule 13G rather than a control-seeking position.

What voting and dispositive powers over CEPT shares does Alyeska report?

The reporting persons disclose zero sole voting and dispositive power, and shared voting and shared dispositive power over 1,763,546 Class A ordinary shares. This means decisions to vote or dispose of these shares are made jointly, rather than by any single reporting person alone.

What date triggered Alyeska’s Schedule 13G filing for Cantor Equity Partners II?

The date of the event requiring the Schedule 13G filing is listed as December 31, 2025. This date reflects when the ownership position met the regulatory threshold that triggered the need to report beneficial ownership of Cantor Equity Partners II, Inc. shares.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Alyeska Investment Group, L.P.
Signature:Jason Bragg
Name/Title:Jason Bragg | Chief Financial Officer
Date:02/17/2026
Alyeska Fund GP, LLC
Signature:Jason Bragg
Name/Title:Jason Bragg | Chief Financial Officer
Date:02/17/2026
Anand Parekh
Signature:Anand Parekh
Name/Title:Anand Parekh | Self
Date:02/17/2026
Exhibit Information

The reporting persons are the beneficial owners of 1,763,546 common shares of the Issuer. The percentage of beneficial ownership is based on 24,580,000 shares of the registrant's common stock outstanding as reported on the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 14, 2025. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.